AKT1 and Parkinson disease: Additionally, in a recent study Cai et al. showed downregulated lncRNA UCA1 ameliorates the damage of dopaminergic neurons in PD rats through the inhibition of the PI3K/Akt signaling pathway, which suggested that UCA1 might be a promising therapeutic target for PD (Cai et al., 2019).